首页> Heart failure reviews> The DIGIT-HF trial and the Mihai Gheorghiade legacy: time to reconsider cardiac glycosides as effective therapy in HFrEF.

The DIGIT-HF trial and the Mihai Gheorghiade legacy: time to reconsider cardiac glycosides as effective therapy in HFrEF.

导出 LinkOut

翻译打印收藏纠错

第一作者： Oliviana,Geavlete

第一单位： Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania.;University of Medicine Carol Davila, Bucharest, Romania.

作者： Oliviana,Geavlete ^[1] ; Andrew P,Ambrosy ^[2] ; Jenna,Skowronski ^[3] ; Magdy,Abdelhamid ^[4] ; Nicolas,Girerd ^[5] ; Tamas,Alexy ^[6] ; Ovidiu,Chioncel ^[1] ; Luca,Monzo ^[7]

作者单位： Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania.;University of Medicine Carol Davila, Bucharest, Romania. ^[1] Department of Cardiology, Kaiser Permanente Medical Centre, San Francisco, CA, USA.;Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA. ^[2] University of North Carolina, Chapel Hill, NC, USA. ^[3] Department of Cardiovascular Medicine, Faculty of Medicine, Kasr Al Ainy, Cairo University, Cairo, Egypt. ^[4] CHRU de Nancy, Centre d'Investigation Clinique Plurithématique 1433, INSERM 1433, Institut de Recherche et d'Innovation en Santé (I.R.I.S.), Rue du Morvan, Université de Lorraine, INSERM U1116 - DCAC, and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France. ^[5] University of Minnesota, Minneapolis, MN, USA. ^[6] CHRU de Nancy, Centre d'Investigation Clinique Plurithématique 1433, INSERM 1433, Institut de Recherche et d'Innovation en Santé (I.R.I.S.), Rue du Morvan, Université de Lorraine, INSERM U1116 - DCAC, and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France. l.monzo@tiscali.it. ^[7]

关键词 DIGIT-HF Digitoxin Digoxin Heart failure